Cabergoline ZPHC — 0.25 mg × 50 tablets

Cabergoline — prolactin-control research compound
50 film-coated tablets × 0.25 mg
Main function: lowers serum prolactin by activating pituitary D₂ receptors, keeping levels in the low-normal range.
When it’s used: Trenbolone / Nandrolone studies, hyper-prolactinaemia models, libido or erectile-function research.
Typical research dosing: 0.25 mg twice weekly
(bloodwork-guided ceiling ≈ 1 mg / week).
Expected benefits: prevents gynecomastia, water retention, mood swings, low libido and “tren cough” associated with high prolactin.
Monitoring advice: track prolactin, blood pressure and mild CNS side-effects (yawning, light-headedness).
QC: ≥ 99 % API purity (HPLC) • GMP tablet press • tamper-evident cap with scratch-code authenticity., Cabergoline ZPHC — 0.25 mg × 50 tablets, 66, USD, ,